The United States contributes substantially to the North American market due to its well-established healthcare system, high healthcare expenditure, and growing emphasis on reducing hospital acquired infections. Increasing demand for effective antibiotics, improved infection control protocols, and advanced treatment options is expected to support market growth. According to The Insight...